InvestSMART

AVITA Medical, Inc. (ASX: AVH) - Announcements

Current share price for AVH : $1.395 0.045 (3.33%)+

ASX company news and announcements for AVITA Medical, Inc. (AVH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All AVITA Medical, Inc. (AVH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than AVITA Medical, Inc. (AVH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for AVITA Medical, Inc. (AVH)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$120 Appendix 4C - quarterly 30 Oct 2009 8:23AM $0.155 $1.395 risen by 800%
$120 Japanese Patent Granted 6 Oct 2009 8:29AM $0.165 $1.395 risen by 745.45%
$120 Preliminary Final Report 31 Aug 2009 1:45PM $0.170 $1.395 risen by 720.59%
$120 ReCell Cleared for Sales in China 17 Aug 2009 8:28AM $0.200 $1.395 risen by 597.50%
$120 USA ReCell AFIRM Clinical Study to Commence 13 Aug 2009 8:25AM $0.120 $1.395 risen by 1,062.50%
$120 Appendix 4C - quarterly 31 Jul 2009 10:09AM $0.100 $1.395 risen by 1,295%
$120 Secures $5m Funding Facility 20 Jul 2009 8:30AM $0.098 $1.395 risen by 1,323.47%
$120 Awarded $2m to accelerate approval in US market 27 May 2009 9:30AM $0.125 $1.395 risen by 1,016%
$120 Quarterly Cash Flow 1 May 2009 8:22AM $0.087 $1.395 risen by 1,503.45%
$120 Respiratory Sales up 72% 2 Apr 2009 9:54AM $0.078 $1.395 risen by 1,688.46%
$120 Half Yearly Report and Accounts 27 Feb 2009 2:32PM $0.074 $1.395 risen by 1,785.14%
$120 Avita Streamlines Operations and Reduces costs 11 Feb 2009 8:28AM $0.100 $1.395 risen by 1,295%
$120 Quarterly Cash Flow - Cash receipts up over 600% 30 Jan 2009 9:18AM $0.090 $1.395 risen by 1,450%
$120 Avita Medical Receives ISO Certification 14 Jan 2009 8:25AM $0.080 $1.395 risen by 1,643.75%
$120 French Ministry of Health in 200 Patient ReCell Study 16 Dec 2008 8:27AM $0.039 $1.395 risen by 3,476.92%
$120 Appendix 4C - quarterly 31 Oct 2008 8:30AM $0.041 $1.395 risen by 3,302.44%
$120 US Patent Application for Cell Delivery Device 16 Oct 2008 8:28AM $0.043 $1.395 risen by 3,144.19%
$120 Preliminary Final Report 29 Aug 2008 8:24AM $0.057 $1.395 risen by 2,347.37%
$120 Greek Distributor Funhaler - ReCell Approval Mexico 7 Aug 2008 9:39AM $0.092 $1.395 risen by 1,416.30%
$120 Appendix 4C - quarterly 30 Jul 2008 8:30AM n/a $1.395 n/a
$120 Sales and Marketing Update 16 Jul 2008 8:28AM $0.130 $1.395 risen by 973.08%
$120 ReCell China Regulatory Update 3 Jul 2008 11:55AM $0.130 $1.395 risen by 973.08%

1326 - 1347 of 1347 results

Page 54 of 54

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.